Miltényi L, Sallay A, Dézsi Z, Matolay G, Szatai I, Borbély T, Vargha G
Strahlentherapie. 1980 Mar;156(3):162-6.
The authors are presenting the 5-year survival rates of 170 patients treated for carcinoma of the lip at the radiological department of the Medical University in Debrecen. The results of radiation therapy, clarified and stage-correlated, are as follows: T1 100%, T2 90.2%, T3 67.9%. They call attention to the fact that in planning and carrying out the schedule of radiation treatment its effectiveness is stage-dependent. In radiation treatment applied in conformity with this, the basic laws of radiation therapy have to be observed. In the treatment of Stages T1 the optimal added-up radiation effectiveness lies at 2000 to 2500 reu with Chaoul tubes 1 and 2, for Stages T2 at 2300 to 2600 reu with Chaoul tubes 3 and 4, for Stages T3 at 2500 to 2600 reu with Chaoul tubes 3, 6 or 10 and additional telecobalt irradiation of the corresponding lymphatic chains.
作者公布了德布勒森医科大学放射科收治的170例唇癌患者的5年生存率。经明确并与分期相关的放射治疗结果如下：T1期为100%，T2期为90.2%，T3期为67.9%。他们提醒注意，在制定和实施放射治疗方案时，其疗效取决于分期。在依此进行的放射治疗中，必须遵守放射治疗的基本规律。在T1期治疗中，使用1号和2号超高压X线管时，最佳总放射剂量为2000至2500伦琴当量；T2期使用3号和4号超高压X线管时为2300至2600伦琴当量；T3期使用3号、6号或10号超高压X线管并对相应淋巴链进行附加钴远距离照射时为2500至2600伦琴当量。
